Significant increase in the proportion of neutrophils within cSCC vs. surrounding skin (p < 0.01), with TANs accounting for 30–80% of tumor-infiltrating CD45+ cells. TANs contribute to cSCC development by limiting effector CD8+ T cell responses. The gene discussed is PTPRC; the disease is neoplasm.